CYCC:Cyclacel Pharmaceuticals Inc - Stock Price Quote and Dividend Data
LATEST CLOSE STOCK PRICE
Projected 10 Year Dividend Yield125.00%
Dividend Yield 5 Year Average0.00%
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeReverse Split
Dividend Declaration DateMay. 26, 2016
Dividend Ex DateJul. 13, 2016
Dividend Record DateJul. 17, 2016
Dividend Pay DateAug. 01, 2016
Dividend Amount Current$0.150
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid2016
52-Week Low/High Stock Price$0.28 - $1.87
Percent Held by Institutions13.17%
PE Ratio to Industry47%
Debt-Equity to Industry3.68%
Total Return Last 12 Months-68.00%
Total Return Last 3 Years-93.07%
Total Return Last 5 Years-98.74%
Latest Trade DateAug. 20, 2019
No Data available for Payment History.
Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company. Co. utilizes its knowledge in cell cycle, transcriptional regulation and deoxyribonucleic acid (DNA) damage response biology in cancer cells to develop targeted medicines for cancer and other serious diseases. Co.'s Cyclin Dependent Kinase (CDK) Inhibitors are a family of enzymes discovered as regulators of the cell cycle, but also provide pivotal functions in the regulation of transcription, DNA repair and metastatic spread. Seliciclib, Co.'s primary CDK inhibitor, is being evaluated in an all-oral Phase 1/2 combination study with Co.'s sapacitabine in patients with BRCA mutations.
SegmentPharmaceuticals & Biotechnology
Dividend AllStar™ Ranking
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Aug. 14, 2019CLOSE PRICE DECREASE: Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) on 08-14-2019 decreased close price > 10% from $0.50 to $0.44Read more...
Jul. 31, 2019CLOSE PRICE INCREASE: Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) on 07-31-2019 increased close price > 10% from $0.52 to $0.59Read more...
May. 29, 2019CLOSE PRICE DECREASE: Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) on 05-29-2019 decreased close price > 10% from $0.76 to $0.68Read more...
Aug. 21, 2019CLOSE PRICE DECREASE: Innovus Pharmaceuticals Inc (OTCBB: INNV) on 08-21-2019 decreased close price > 10% from $1.75 to $1.50Read more...
Aug. 21, 2019CLOSE PRICE DECREASE: Veritas Pharma Inc (OTCBB: VRTHF) on 08-21-2019 decreased close price > 10% from $0.32 to $0.28Read more...
Aug. 21, 2019CLOSE PRICE DECREASE: Thrombogenics NV (OTCBB: TBGNF) on 08-21-2019 decreased close price > 10% from $5.20 to $3.49Read more...